NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related
Por um escritor misterioso
Descrição
IA2 and Splaine Consulting have created policy report for American Indian and Alaska Native Alzheimer's Disease and Related Dementia Issues
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial - The Lancet
With More Than 250,000 Alzheimer's Patients, VA Is a Market for New Drug - U.S. Medicine
Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer's Disease: Using the Multiomics Approach
CDC: Subjective cognitive decline more prevalent in underrepresented populations
Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 - The Lancet Public Health
Awareness of Alzheimer's Disease — LEB
Multi-ancestry meta-analysis and fine-mapping in Alzheimer's disease
A feat in medicine: A new Alzheimer's drug offers hope
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
The Shape of the Brain: Spatial Biology of Alzheimer's Disease, Science Lab
Resource - Dementia Risk Reduction Flyers - International Association for Indigenous Aging
Dementia Man: An Existential Journey, Theater
Will there ever be a cure for Alzheimer's disease?
de
por adulto (o preço varia de acordo com o tamanho do grupo)
